RxDoctor Payments Data

Amos Sit, MD

Surgery · Shreveport, LANPI 1164866158

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (49.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 86.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $8,607 and has fallen 71.8% since, to $2,425 in 2025. Among surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,602in general payments, 2019–2025

Across 122 payments — averaging $234.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$25K
  • Davol Inc.$3K
  • Medical Device Business Services, Inc.$230
  • Kerecis Limited$145
  • Smith+Nephew$100
  • Coopersurgical, Inc.$71
  • plus $240 from 6 others

What the payments were for

  • Travel & lodging$10,64337%
  • Food & beverage$3,87114%
  • Education$14,07249%
  • Gifts$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,602 in reported general payments places this provider in the 90th percentile of 381 surgery providers in Louisiana.

See all surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$33,590
Medicare patients
92
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine43$390
Pantoprazole Sodium24$335
Omeprazole11$27

Paid to pharmacies, not to this prescriber.

Other surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →